129 related articles for article (PubMed ID: 19564516)
1. The ability of the quadruple test to predict adverse perinatal outcomes in a high-risk obstetric population.
Lao MR; Calhoun BC; Bracero LA; Wang Y; Seybold DJ; Broce M; Hatjis CG
J Med Screen; 2009; 16(2):55-9. PubMed ID: 19564516
[TBL] [Abstract][Full Text] [Related]
2. Quad screen as a predictor of adverse pregnancy outcome.
Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
[TBL] [Abstract][Full Text] [Related]
3. Risk prediction for Down's syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis.
Hwa HL; Ko TM; Hsieh FJ; Yen MF; Chou KP; Chen TH
J Eval Clin Pract; 2007 Apr; 13(2):254-8. PubMed ID: 17378872
[TBL] [Abstract][Full Text] [Related]
4. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
Wald NJ; Morris JK; Ibison J; Wu T; George LM
Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis-derived parameters.
Reynolds TM; Vranken G; Van Nueten J; Aldis J
Int J Clin Pract; 2008 May; 62(5):735-43. PubMed ID: 17590221
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of second trimester maternal serum screening for Down's Syndrome using the Spiegelhalter-Knill-Jones (S-KJ) approach.
Hwa HL; Yen MF; Hsieh FJ; Ko TM; Chen TH
J Perinat Med; 2004; 32(5):407-12. PubMed ID: 15493716
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction.
Odibo AO; Sehdev HM; Stamilio DM; Macones GA
Am J Perinatol; 2006 Aug; 23(6):363-7. PubMed ID: 16841275
[TBL] [Abstract][Full Text] [Related]
8. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
9. First- and second-trimester evaluation of risk for Down syndrome.
Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
[TBL] [Abstract][Full Text] [Related]
10. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of quad serum markers for adverse pregnancy outcome in antiphospholipid antibody syndrome.
Hong SY; Kim SY; Kim JH; Hong JY; Sung JH; Choi SJ; Oh SY; Roh CR
Lupus; 2021 May; 30(6):981-990. PubMed ID: 33709835
[TBL] [Abstract][Full Text] [Related]
12. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
13. Introduction of a nomogram for predicting adverse pregnancy outcomes based on maternal serum markers in the quad screen test.
An JJ; Ji HY; You JY; Woo SY; Choi SJ; Oh SY; Roh CR; Kim JH
Arch Gynecol Obstet; 2015 Sep; 292(3):589-94. PubMed ID: 25773358
[TBL] [Abstract][Full Text] [Related]
14. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
[TBL] [Abstract][Full Text] [Related]
15. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
Morris JK; Bestwick J; Wald NJ
J Med Screen; 2008; 15(2):55-61. PubMed ID: 18573771
[TBL] [Abstract][Full Text] [Related]
16. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
Craig WY; Haddow JE; Palomaki GE; Roberson M
Prenat Diagn; 2007 May; 27(5):409-14. PubMed ID: 17286308
[TBL] [Abstract][Full Text] [Related]
17. [Evaluating the applicability of MoM in second trimester maternal serum to screening for Down's syndrome in Jiangsu province].
Xu BY; Hu Y; Zhang CY; Zhang JW; Liu QL; Yue H; Ru T; Xu ZF; Zhu RF; Zhang Y; Zhong X; Wu QM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):32-5. PubMed ID: 18247300
[TBL] [Abstract][Full Text] [Related]
18. The impact of bias in MoM values on patient risk and screening performance for Down syndrome.
Nix B; Wright D; Baker A
Prenat Diagn; 2007 Sep; 27(9):840-5. PubMed ID: 17600858
[TBL] [Abstract][Full Text] [Related]
19. Practicability of using vaginal fluid markers in detecting premature rupture of membranes.
Ni CY; Jia WX; Yi WM; Feng LH; Yu LZ
Ann Clin Biochem; 2003 Sep; 40(Pt 5):542-5. PubMed ID: 14503992
[TBL] [Abstract][Full Text] [Related]
20. [Specificity of biochemical markers of pregnancy second trimester].
Salazar López R; Ibarra Gallardo AL; Iduma Meléndrez M; Leyva Bojórquez R
Ginecol Obstet Mex; 2007 Oct; 75(10):608-14. PubMed ID: 18800579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
